
Spare the Rodrigo: Philippine elections
The Intelligence from The Economist
Challenges in Antibiotic Development
This chapter delves into the difficulties pharmaceutical companies encounter in creating new antibiotics, emphasizing the low profit margins and hefty costs involved. It also examines potential solutions and incentives to stimulate innovation in combating antibiotic resistance.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.